Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: Cancer. 2013 Apr 30;119(15):2728–2736. doi: 10.1002/cncr.28136

Figure 3.

Figure 3

Figure 3

Figure 3

A & B. Slower clearance and higher AUCs were observed in patients achieving marrow CR (CR) versus others (A). Maximum inotuzumab plasma concentrations did not correlate with response. (B)